$69 postpage LB

The Share Price of WHA Zoomed Up By 6.011% After Its Accreditation And Certification of CNCA

  • January 08, 2019 11:20 PM AEDT
  • Team Kalkine
The Share Price of WHA Zoomed Up By 6.011% After Its Accreditation And Certification of CNCA

Wattle Health Australia Ltd (ASX: WHA), from the Food, Beverage & Tobacco sector which is into the business of developing and manufacturing consumer food products in Australia, announced that its Certification and Accreditation of the Peoples Republic of China (CNCA) for manufacturing infant formula got renewed by Blend and Pack Pty Ltd (B&P). B&P is not only the largest independent, nutritional dairy manufacturer in Australia but is also amongst the fifteen CNCA accredited manufacturer for infant formula for the People’s Republic of China which is world’s largest nutritional diary market. B&P produces various domestic and international brands.

Gold MTF non-AMP

WHA being the shareholder of B&P and an important nominated brand of the State Administration of Market Regulation (SAMR), makes it confident in stepping ahead towards the Chinese market after the renewal of Certification and Accreditation of the CNCA.

The official listing date of WHA on ASX is 15 March 2017, where the performance of the company was 373.60%. However, its last year’s performance was -47.81%.

For the FY2018, which ended on 30 June 2018, Wattle Health Australia Ltd made a net loss of $19.839 million. The balance sheet of WHA looks healthy with a strong net asset base of $61.539 million and a debt to equity ratio of 0.045 which indicates that the company is financially sound to manage its long-term obligations. Having a low debt to equity ratio of WHA shows that the company tries to use its resources for funding any financial requirement within the company. However, as compared to the FY2017, there is an increase in the accumulated losses in the fiscal year 2018 by 4.45 times which is an indication of the weak operating performance of the company. Also, it might create a negative influence on the shareholders of the company.

There was an increase in the net cash and cash equivalent of $50.090 million by the end of the fiscal year 2018. The primary source of the cash inflow was through the issue of shares where the company was able to generate around $62.595 million. By the end of the financial year 2018, the net cash and cash equivalent available with Wattle Health Australia Ltd was $55.843 million.

After getting listed on ASX, even though its last one-year performance was quite poor, but it appears that the investors and the shareholders still have hopes with the company as its earlier performance was 373.60%. Above that, its recent announcement of the Certification and Accreditation of the Peoples Republic of China for the manufacture of infant formula might have made them confident that the company is stepping towards its global expansion which might improve the performance of the company shortly.

By the end of the trading on 8 January 2019, the share price of WHA zoomed up by 6.011%. The opening price of the stock was A$0.940 which is also the lowest price of the day. It went as high as A$0.995 with the stock holding a market capitalization of A$177.97 million.


Disclaimer

This website is a service of Kalkine Media Pty. Ltd. A.C.N. 629 651 672. The website has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. Kalkine Media does not in any way endorse or recommend individuals, products or services that may be discussed on this site. Our publications are NOT a solicitation or recommendation to buy, sell or hold. We are neither licensed nor qualified to provide investment advice.

 

 


Disclaimer
The website https://kalkinemedia.com/au is a service of Kalkine Media Pty. Ltd. (Kalkine Media) A.C.N. 629 651 672. The principal purpose of the content on this website is to provide factual information only and does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stock of the company (or companies) or engage in any investment activity under discussion. We are neither licensed nor qualified to provide investment advice through this platform. In providing you with the content on this website, we have not considered your objectives, financial situation or needs. You should make your own enquiries and obtain your own independent advice prior to making any financial decisions.
Some of the images that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed on this website unless stated otherwise. The images that may be used on this website are taken from various sources on the web and are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it below the image. The information provided on the website is in good faith, however Kalkine Media does not make any representation or warranty regarding the content, accuracy, or use of the content on the website.

 

   
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK